From your mom’s meds to your neighbor’s insulin, the 340B program stretches every dollar so nonprofit healthcare providers can care for our communities without raising taxes. Pharma wants every cent.


340B helps your community healthcare provider do more with less by stretching limited resources, allowing community health centers to provide affordable care for millions of families.

Pharma’s attacks on 340B put this proven and beneficial program at risk, threatening rural hospitals and community health centers across the country.

The problem is that the general public is largely unaware of the program, even those who are benefiting from it firsthand. 

Read on to learn the truth about 340B, Pharma’s motives, and join us in defending 340B and, in turn, public health.

The Real Price of Pharma’s Greed

Pharma’s Attacks on 340B Threaten Rural Hospitals

Across the country, 338 rural hospitals are at risk of closing or cutting services because of financial distress.
Already, the U.S. has 50 fewer rural hospitals than in 2017, leaving patients with fewer options for care.
83 hospitals are at high risk of financial collapse, with years of losses and no path to stability.
Louisiana, Kentucky, and Tennessee

In states like Louisiana, Kentucky, and Tennessee, dozens of hospitals have reported losses for three consecutive years.

When rural hospitals shut down, communities lose not only access to emergency rooms, OB care, and mental health services, but also local jobs and economic stability, since hospitals are often the largest employers in the community.

Pharma’s attacks on the 340B program exacerbate this crisis. Instead of helping to keep hospitals open, drug companies are fighting the very program that allows struggling hospitals to stretch limited resources and serve their patients.

When hospitals close, patients lose access to affordable medications, prenatal care, and mental health services. Pharma says 340B is the problem—but the truth is, their profits are at record highs while your local hospital may be forced to shut its doors.

What is 340B?

First established in 1992 through bipartisan legislation, the federal 340B drug discount program operates on the simple principle of requiring drug companies to provide drugs at a discounted price to certain types of nonprofit hospitals and clinics that, in turn, use their 340B savings to provide affordable healthcare in their communities. That reinvestment in patients and communities without taxpayer dollars has made the 340B program successful. 340B providers can do more with their limited dollars to benefit their communities.

For over 30 years, the 340B program has consistently helped safety net providers meet their communities’ unique public health needs. Congress has acted several times to extend program eligibility to additional categories of hospitals. However, despite affecting just two percent of all drug sales in the United States, the program remains deeply unpopular within the drug industry.

Defending the 340B Program

Without a significant and sustained effort to raise public awareness of the 340B program’s benefits, the program faces an uncertain future. Providers and their healthcare industry supporters have worked to defend the 340B program, recognizing its actual value in providing patients with affordable care, but they need the help of you and other Americans.

ACT NOW to defend the 340B program against ongoing attacks by the drug industry.

Take Action With Us

Contact Your Lawmaker. Tell Congress to protect 340B and the support you and your community health centers depend on.

Ready to act now? Send a message to your policymaker today asking them to #Defend340B.

Don’t let Big Pharma shrink the program that’s helping thousands access affordable healthcare.

Subscribe to Our Email List

Stay informed. Stay ready. Don’t miss a move in the fight to protect 340B.

"*" indicates required fields

This field is hidden when viewing the form

Next Steps: Sync an Email Add-On

To get the most out of your form, we suggest that you sync this form with an email add-on. To learn more about your email add-on options, visit the following page (https://www.gravityforms.com/the-8-best-email-plugins-for-wordpress-in-2020/). Important: Delete this tip before you publish the form.
Name*

Background on 340B Drug Pricing Program

Section 340B of the Public Health Service Act
The federal 340B Drug Discount Program is a lifeline that allows safety net providers to obtain prescription drugs at below-retail prices. The program was established with bipartisan support as part of the Veterans Health Care Act of 1992.

Health Resources & Services Administration (HRSA)
Office of Pharmacy Affairs, located within the Health Resources and Services Administration of the Department of Health and Human Services, administers the 340B program. HRSA and OPA are located in Rockville, MD, and are responsible for interpreting and implementing the 340B law.

OPA Information System (OPAIS)
Find 340B covered entities near you. Search the Office of Pharmacy Affairs Database to find Disproportionate Share Hospitals; Federally Qualified Health Centers; Rural Referral Centers; Sole Community Hospitals; Community Health Centers; Hemophilia Treatment Facilities; and Ryan White Clinics that rely on the 340B program.

Myth vs. Fact – 340B Coaltion
There’s a lot of misinformation about the 340B program out there. Get the facts about the intent of the program, who benefits from the 340B program, and why the 340B program is necessary to communities across the country.

Key Acronyms and Terms Related to the 340B Program
340B Health has listed several key acronyms and terms related to the 340B program. This includes government agencies, types of covered entities, legislation, nonprofit organizations, vendors, and more.